Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000182827 | SCV000235213 | uncertain significance | not provided | 2014-04-18 | criteria provided, single submitter | clinical testing | p.Ala4204Val (GCT>GTT): c.12611 C>T in exon 90 of the RYR2 gene (NM_001035.2). The A4204V variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The A4204V variant was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A4204V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. A missense mutation in a nearby residue (Q4201R) has been reported in association with CPVT, supporting the functional importance of this region of the protein. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in ARRHYTHMIA panel(s). |